Speciality: Pacing Technician
Speciality: Cardiac Physiologist
Location: Beds and Herts
Speciality: BSE Echo
Speciality: BSE Echocardiographer
Location: South East Coast
The production of highly functional new blood cells could be stimulated in oxygen-starved tissues, research has revealed.
A study, published online in Nature Biotechnology, found that if a biological factor, known as fibroblast growth factor 9 (FGF9), is delivered at the same time the body is trying to form new blood vessels in damaged tissue, it becomes a successful attempt.
Dr Pickering, of the Robarts Research Institute, indicated that the discovery could be used in cardiac patients.
"Coronary bypass surgery and stenting are important treatments but are not suitable for many individuals," he said.
"Because of this, there has been considerable interest in recent years in developing biological strategies that promote the regeneration of a patient's own blood vessels."
This follows news that a promising blood thinning drug known as Dabigatran etexilate could lessen the risk of stroke in atrial fibrillation patients.
The drug, known as Pradaxa, could change the lives of people with heart rhythm disorders, after research found that the medication cut the risk of stroke by between 30 and 39 per cent.
Written by Angela Newbury
A team of researchers at Russell de Souza of McMaster University in Ontario analysed a total of 123 studies...
New research has proved beyond doubt that people with type 1 diabetes have half the risk of dying from cardiovascular...
Annual figures from NHS Blood and Transplant have revealed that the number of people waiting for a heart transplant...
A research team in the US say they have made an important breakthrough that is a significant step towards...